Altimmune, Inc. - 10-Q Filing

Altimmune, Inc. reports quarterly results for the period ended September 30, 2026, featuring significant equity activity and secured debt tranches.

SEC EDGAR ·

Tickers: $ALT

Read the full article at SEC EDGAR

More Regulatory news